Moreover, it has been demonstrated in both animal models and clinical experiments that the administration of sclerostin antibody is markedly effective in the prevention of osteoporosis after the decrease in estrogen level [22, 34, 35]. The gene discussed is SOST; the disease is osteoporosis.